Position in ALVO
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$269,073
-$107,263 QoQ
Shares Held
78,447
+6.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $1,834,470,034 across 45 Drug Manufacturers - Specialty & Generic names. ALVO ranks #40 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,540,968 | $418,577,820 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
608,367 | $360,749,459 | |
| 3 | VTRS |
Viatris Inc
|
21,968,657 | $296,796,550 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
8,141,172 | $194,818,243 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,253,233 | $97,987,373 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
1,591,909 | $52,644,427 | |
| 7 | PRGO |
PERRIGO Co plc
|
4,711,783 | $50,604,546 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,561,763 | $47,602,534 |
All Filings in ALVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $269,073 | 78,447 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $376,336 | 73,360 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $381,457 | 46,576 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $295,469 | 32,398 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $228,250 | 23,604 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $148,308 | 11,210 | Shares | Defined | 2025-02-13 | |
| 2023-03-31 | $1,887,915 | 146,350 | Shares | Defined | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||